Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients

INTRODUCTION: Critically ill hospitalized patients are at increased risk of infection so we assessed the immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPSV23) administered within six days of injury. METHODS: This prospective observational study compared the immunogenicity of PPSV2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Scott W., Baumgartner, Laura J., MacLaren, Rob, Neumann, Robert, Wiktor, Arek J., Kiser, Tyree H., Lindberg, Gordon, Cava, Luis, Fish, Douglas N., Janoff, Edward N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951595/
https://www.ncbi.nlm.nih.gov/pubmed/29758059
http://dx.doi.org/10.1371/journal.pone.0197037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951595/
https://www.ncbi.nlm.nih.gov/pubmed/29758059
http://dx.doi.org/10.1371/journal.pone.0197037

Ejemplares similares